Literature DB >> 6732189

Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease.

I Nakano, A Hirano.   

Abstract

A representative region of the nucleus basalis of Meynert was investigated in 11 patients with idiopathic Parkinson's disease and compared with the identical region in 13 age-matched control subjects. Simultaneously, the cerebral cortex and the nucleus basalis in the patients with Parkinson's disease were examined for senile plaques and Alzheimer's neurofibrillary tangles. The nucleus basalis was significantly depleted of its large neurons in Parkinson's disease (p less than 0.001 versus controls; Student t tests), but in the majority of cases the neuron loss was not associated with Alzheimer's disease.

Entities:  

Mesh:

Year:  1984        PMID: 6732189     DOI: 10.1002/ana.410150503

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  57 in total

1.  An update on brain imaging in parkinsonian dementia.

Authors:  Myria Petrou; Vikas Kotagal; Nicolaas I Bohnen
Journal:  Imaging Med       Date:  2012-04

2.  Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2010-08-19       Impact factor: 17.088

3.  The nucleus basalis of Meynert in 20 definite cases of Creutzfeldt-Jakob disease.

Authors:  L Cartier; R Verdugo; C Vergara; S Galvez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

4.  Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.

Authors:  R Ceravolo; D Volterrani; D Frosini; S Bernardini; C Rossi; C Logi; G Manca; L Kiferle; G Mariani; L Murri; U Bonuccelli
Journal:  J Neural Transm (Vienna)       Date:  2006-06-14       Impact factor: 3.575

Review 5.  Recognition and management of neuropsychiatric complications in Parkinson's disease.

Authors:  Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

Review 6.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

Review 7.  The pathology roadmap in Parkinson disease.

Authors:  D James Surmeier; David Sulzer
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

Review 8.  Parkinson's disease in 1984: an update.

Authors:  A E Lang; R D Blair
Journal:  Can Med Assoc J       Date:  1984-11-01       Impact factor: 8.262

Review 9.  Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.

Authors:  Martin Sarter; Roger L Albin; Aaron Kucinski; Cindy Lustig
Journal:  Exp Neurol       Date:  2014-05-05       Impact factor: 5.330

10.  The nucleus basalis of Meynert in multi-infarct (vascular) dementia.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.